Clinical researchers are scientists, clinicians and technical builders who run neuroscience and clinical studies and need specialized recording or implant technology. They are usually in their late twenties to fifties. Brands that sell to them include Emotiv, OpenBCI, Synchron, Kernel and Blackrock Neurotech, offering EEG headsets, open-source biosensing hardware, non-invasive brain recording and implantable interfaces. Studying their ads shows how deep-tech companies speak to expert buyers: what proof they lead with, how they frame research use, and how they balance technical credibility with an approachable story.
They read specifications and evaluate claims. Vague hype lowers credibility fast.
Purchases are tied to funded projects, lab budgets and study timelines, so the sales process is slow and deliberate.
They want evidence the hardware produces reliable signals, ideally in published or peer-reviewed work.
Some, including academics, engineers and hobbyists, value open, hackable tools and a developer community.
For implant and patient-facing work, safety, regulation and ethics are central to the decision.
Conferences, journals, LinkedIn and research communities carry more weight than broad consumer feeds.

Blackrock Neurotech is a medical device company developing brain-computer interface implants used to help people with paralysis and neurological conditions control external devices and communicate through neural signals. The company has a long history in neural recording technology, working closely with research hospitals and clinical trial programs. It operates in the medical device and neurotechnology category rather than as a consumer retail brand.

Emotiv is a neurotechnology company selling EEG headsets and brain-computer interface devices used for research, wellness, and productivity applications. Based in San Francisco, the company sells hardware and software direct-to-consumer and to research institutions. It advertises across Meta placements to reach technology and biohacking audiences.

Kernel is a neurotechnology company developing non-invasive brain-recording devices used for research into brain function and mental health. Its headset-based technology is aimed primarily at research institutions and clinical studies rather than general consumers. The company operates in the emerging neurotech and brain-imaging hardware category.

OpenBCI is a brain-computer interface company selling open-source EEG and biosensing hardware used by researchers, developers, and hobbyists. The company sells direct-to-consumer through its own site, targeting a technical and research-oriented audience. It advertises across Meta placements to support ecommerce sales.

Synchron is a medical technology company developing brain-computer interface implants that allow people with paralysis to control digital devices using neural signals, delivered via a minimally invasive endovascular procedure rather than open brain surgery. The company is positioned in the emerging neurotechnology and BCI category, working with research institutions and regulators on clinical trials. It is not a direct-to-consumer retail brand.
Lead with substance. This audience wants to know what the device measures, how, and what has been done with it. The sample brands show a spread: Emotiv and OpenBCI emphasize accessible EEG and open biosensing, Kernel highlights non-invasive brain recording for research, and Synchron and Blackrock Neurotech speak to implant-based work for paralysis and neurological conditions. Choose creative that carries proof: lab footage, device close-ups, data visualizations and short explainers by the scientists who built the product. Avoid dramatic futuristic imagery that promises more than a study can support. Plain language about use cases, such as research, clinical studies or development, signals respect. Calls to action should match the buying process. Instead of an immediate purchase, offer a spec sheet, a webinar, a demo request or a link to publications and documentation. For open hardware, point to the developer community and tutorials. Be careful with medical claims. Describe what a tool is designed to do and for whom, not outcomes you cannot substantiate. Trust is the entire asset in this market.
Researchers buy when a tool fits a specific study and can be justified to a lab or institution. Ads that name the research problem do better than ads that celebrate the technology. Expect a longer path: initial awareness, technical evaluation, peer recommendation, then purchase through a grant or budget. Credibility signals matter. Collaborations with universities and clinics, publications, transparent specs and visible expertise reduce risk. For implantable and clinical technology, ethics and regulatory framing are part of the message, not a footnote. When you research these brands in AdLibrary, compare whether ads target researchers, developers or the broader public, how often technical proof appears and which calls to action repeat. Open-source positioning, as seen with OpenBCI, creates a different story from regulated medical devices. Common mistakes include overpromising, using consumer-style hype and hiding technical details behind a form. A better pattern is to be specific, cite what is known and give experts an easy way to go deeper.
Examples include Emotiv, OpenBCI, Synchron, Kernel and Blackrock Neurotech. They offer EEG headsets, open-source biosensing hardware, non-invasive brain recording devices and brain-computer interface implants for research and clinical use. Their ads show how very different technology, from open hardware to implants, is pitched to expert buyers.
They tend to lead with technical credibility: lab and device visuals, research use cases and expert explainers. Calls to action often offer demos, documentation or webinars instead of an immediate purchase. Language stays precise and cautious, because exaggerated claims quickly cost credibility with this audience.
Professional and research-oriented channels such as LinkedIn, conferences and academic communities carry weight. Targeted social ads can support them when the message is specific and evidence-led. Message specificity matters more than reach, since the buying group is small and highly informed.
Check how claims are worded, what proof is shown, who the ad addresses and what next step it offers. Careful, specific language usually signals a brand built for expert buyers. Compare how each brand addresses research versus clinical use, and what level of technical detail appears.
Search and save ads from every brand above across Facebook, Instagram, TikTok and more.
See all ads on AdLibrary →